neo-angin® sugarfree throat lozenges

Product Characteristics

The formulation of neo-angin® sugarfree throat lozenges may vary slightly in specific countries. Please contact us for further information.

1. Name of the product
neo-angin® sugarfree throat lozenges

2. Prescription status/available in pharmacies only
available in pharmacies only

3. Composition of medicinal product

3.1 Substance or indication group
oromucosal use

3.2 Active components according to type and quantity

one lozenge contains:
2,4-dichlorbenzyl alcohol 1.20 mg
amylmetacresol 0.60 mg
menthol 5.72 mg

3.3 Excipients
liquid maltitol, flavouring, colouring E124

4. Areas of application
For disinfection of the oral and pharyngeal cavities with sore throat, hoarseness, catarrh, colds, angina, inflammations of the oral and pharyngeal cavities as well as inflammations of the gums.

5. Contraindication
not suitable for children under 6 years

6. Side effects
none known

7. Interactions with other drugs
none known

8. Special warnings
none known

9. Most important incompatibilities
none known

10. Dosage with single and daily administration
Unless otherwise prescribed, adults and children over 6 years of age should allow one lozenge to dissolve slowly in the mouth every 2-3 hours

11. Method and duration of application
oromucosal use, not limited

12. Emergency measures, symptoms and antidotes
none known

13. Pharmacological and toxicological properties, pharmacokinetics and bioavailablability to the extent that this information is required for therapeutic use
neo-angin® sugarfree throat lozenges are effective against almost all gram-positive and gram-negative bacteria which occur in the oral and pharyngeal cavities as well as fungi and yeasts. The rapid bactericidal effect deserves special emphasis. In addition to the antiseptic effect, menthol has pain-alleviating and secretion-restricting effects on the mucosa.

Through the properties described above neo-angin® combats and alleviates the symptoms of inflammatory catarrhal infections of the mouth and throat. It is well tolerated and has a pleasant flavour.

14. Other information
Diabetics should note that one lozenge corresponds to 0.22 BU. The sugar replacement substance, liquid maltitol (Lycasin®), is broken down with the help of insulin.

15. Shelf life
2 years

16. Special precautions for storage
Lycasin tablets are hygroscopic; that is, they draw moisture from the environment.
When storing for a longer time period, they should therefore be kept in a cool and dry place. The preparation must not be administered after the expiration date.

17. Presentation and pack size
packs with 24 and 48 lozenges

18. Date of information
January 1999

19. Name or company and address of the pharmaceutical enterprise
Divapharma-Knufinke
Arzneimittelwerk GmbH
Motzener Str. 41
12277 Berlin
Telephone (030) 72007-266

back
 

Contact

Contact

Contact

You will find more detailed information on our distribution possibilities here.

 
 
top